Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.
about
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1Vitamin D and bone health: potential mechanisms.Metabolomic profiles delineate signature metabolic shifts during estrogen deficiency-induced bone loss in rat by GC-TOF/MSFollicle-stimulating hormone, interleukin-1, and bone density in adult women.Addition of aerobic exercise to a weight loss program increases BMD, with an associated reduction in inflammation in overweight postmenopausal womenInfluence of interleukin-1 receptor antagonist gene polymorphism on disease.The Anti-Inflammatory Actions of Exercise TrainingLong-term aerobic exercise and omega-3 supplementation modulate osteoporosis through inflammatory mechanisms in post-menopausal women: a randomized, repeated measures studyImpact of targeted PPARγ disruption on bone remodeling.Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women.Effects of Gengnianchun on learning and memory ability, neurotransmitter, cytokines, and leptin in ovariectomized rats.Modifiable risk factors associated with bone deficits in childhood cancer survivors.Inflammatory markers and the risk of hip fracture: the Women's Health Initiative.Negative association between trunk fat, insulin resistance and skeleton in obese women.Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.Differentially expressed genes in PPARγ-deficient MSCs.Effects of hormone replacement therapy on immunological factors in the postmenopausal period.Response of biochemical markers of bone turnover to estrogen treatment in post-menopausal women: evidence against an early anabolic effect on bone formation.Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort.The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis.Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.Effects of combined estrogen/testosterone therapy on bone and body composition in oophorectomized women.The impact of chronic inflammation on bone turnover in hemodialysis patients.Interleukin-6, transforming growth factor-beta 1, and bone markers after kidney transplantation.Serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and their association with markers of bone metabolism in vitamin D-deficient female students.
P2860
Q24804802-B0B69452-D8A7-4A6E-8C3F-B71E9A6950E9Q27690804-569BAF1D-89DF-4D67-90A7-1D4252604080Q28486063-B9253540-876B-4E17-BD0B-3B4B660CEE19Q33728125-E23F6F90-A383-4265-8DE1-9E9CE90C619AQ34080333-7F914B6C-49AE-402D-B5C6-D96F3248A352Q34461355-076BAB43-29B3-4FB9-B9E4-5D3128CAAAC4Q34569544-A7F4478B-5203-42E6-8662-BF0E7FE2500BQ35540651-F77AE0C4-C0C8-468A-898E-370B08F38CB4Q35648762-F796358E-C8E8-4535-934A-749FD1AE2BEAQ35853618-0A80958B-13B6-4F1A-BA16-B8AB481EED08Q35959096-AA353655-1050-459E-A8CC-532F02AE37E4Q35959871-55DFF4B7-4763-446D-887D-7C6E584E200CQ35992176-6F8F5057-2362-43F5-A511-D31F327BBECAQ36768908-5CEB16D4-FD88-4BB1-9A83-F2EFF2CF1E2AQ37801555-CE12B377-B7C0-460D-A0C3-36A33D30FCC8Q38642592-B555C3FA-9D35-45E2-9603-1F9D3EC49C00Q38810278-EB5AC459-1166-4DAF-AA3D-76C9ADDA0E59Q43659724-120319D6-EB17-4B16-8C73-A2CAC76E6829Q45137480-8319111C-8C7D-49E0-A02A-6C280BA03EDBQ45179662-0D8FA2D7-7445-4C0D-AE8A-02B9669F60C7Q45895363-39741937-7EF5-4961-B142-B69E4928E281Q46600435-93C1ABF4-A3DA-450A-9951-C17AF11E9D92Q47677138-DCB7E532-AE3F-4003-AA3C-917C9FECFD48Q47901661-E08E26CB-67AF-4BAA-8288-1757906644E3Q51316276-B535679A-3813-425C-A8F6-5A203E2937A7
P2860
Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Cytokines and bone loss in a 5 ...... Osteoporosis Prevention Study.
@en
Cytokines and bone loss in a 5 ...... Osteoporosis Prevention Study.
@nl
type
label
Cytokines and bone loss in a 5 ...... Osteoporosis Prevention Study.
@en
Cytokines and bone loss in a 5 ...... Osteoporosis Prevention Study.
@nl
prefLabel
Cytokines and bone loss in a 5 ...... Osteoporosis Prevention Study.
@en
Cytokines and bone loss in a 5 ...... Osteoporosis Prevention Study.
@nl
P2093
P2860
P1476
Cytokines and bone loss in a 5 ...... Osteoporosis Prevention Study.
@en
P2093
Beck-Nielsen H
Bonnevie-Nielsen V
Ebbesen EN
P2860
P304
P356
10.1359/JBMR.2000.15.8.1545
P577
2000-08-01T00:00:00Z